Economic evaluation of a surveillance program of hepatocellular carcinoma (HCC) in India

Hepatology International

Volumn 2, Issue 2, 2008, Pages 231-236

  Paul, Shashi Bala ^a   Sreenivas, Vishnubhatla ^a   Gulati, Manpreet Singh ^a   Madan, Kaushal ^a   Gupta, Arun Kumar ^a   Mukhopadhyay, Sima ^a   Acharya, Subrat Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cost effectiveness; Direct medical cost; Direct non medical cost; Hepatocellular carcinoma; Indirect cost

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; BLOOD ANALYSIS; CANCER SCREENING; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; ECHOGRAPHY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INCIDENCE; INDIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE;

EID: 69749085200     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-008-9054-5     Document Type: Article

References (18)

1. 1. L Bolondi S Sofia S Siringo S Gaiani A Casali G Zironi 2001 Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis Gut 48 251 9 11156649 10.1136/gut.48.2.251 1:STN:280:DC%2BD3M7is1WnsQ%3D%3D Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis. Gut. 2001;48:251–9.
2. 2. S Mima C Sekiya H Kanagawa H Kohyama K Gotoh H Mizuo 1994 Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan J Gastroenterol Hepatol 9 361 5 7524721 10.1111/j.1440-1746.1994.tb01256.x 1:STN:280:ByqD3srptlM%3D Mima S, Sekiya C, Kanagawa H, Kohyama H, Gotoh K, Mizuo H, et al. Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan. J Gastroenterol Hepatol. 1994;9:361–5.
3. 3. MF Yuen CL. Lai 2003 Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness Ann Oncol 14 1463 7 14504044 10.1093/annonc/mdg400 Yuen MF, Lai CL. Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness. Ann Oncol. 2003;14:1463–7.
4. 4. P Pisani DM Parkin J. Ferlay 1993 Estimates of the world wide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden Int J Cancer 55 891 3 8253525 10.1002/ijc.2910550604 1:STN:280:ByuD2srgsFY%3D Pisani P, Parkin DM, Ferlay J. Estimates of the world wide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer. 1993;55:891–3.
5. 5. J Bruix M Sherman JM Llovet M Beaugrand R Lencioni AK Burroughs 2001 EASL Panel of Experts on HCC. EASL panel of experts on HCC: clinical management of hepatocellular carcinoma. Conclusions of the Barcelona EASL conference. European Association for the study of liver J Hepatol 35 421 30 11592607 10.1016/S0168-8278(01)00130-1 1:STN:280:DC%2BD3MrksFCmtg%3D%3D Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. EASL Panel of Experts on HCC. EASL panel of experts on HCC: clinical management of hepatocellular carcinoma. Conclusions of the Barcelona EASL conference. European Association for the study of liver. J Hepatol. 2001;35:421–30.
6. 6. JM Llovet A Burroughs J. Bruix 2003 Hepatocelluar carcinoma Lancet 362 1907 17 14667750 10.1016/S0140-6736(03)14964-1 Llovet JM, Burroughs A, Bruix J. Hepatocelluar carcinoma. Lancet. 2003;362:1907–17.
7. 7. JM. Eisenberg 1989 Clinical economics: a guide to the economic analysis of clinical practices J Am Med Assoc 262 2879 86 10.1001/jama.262.20.2879 1:STN:280:By%2BD2c7hsFY%3D Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. J Am Med Assoc. 1989;262:2879–86.
8. 8. MF Drummond O’ Brien GL Stoddart GW. Torrence 1997 Methods for the economic evaluation of health care programmes Oxford University Press Oxford Drummond MF, Brien O’, Stoddart GL, Torrence GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997.
9. 9. SB Paul SK Acharya V Sreenivas MS Gulati K Madan AK Gupta 2006 Incidence of hepatocellular carcinoma among Indian patients of cirrhosis of liver J Gastroenterol Hepatol 21 A 466 Paul SB, Acharya SK, Sreenivas V, Gulati MS, Madan K, Gupta AK et al. Incidence of hepatocellular carcinoma among Indian patients of cirrhosis of liver. J Gastroenterol Hepatol. 2006;21:A 466.
10. 10. World Bank. The World Development Report. Washington, DC; 2004.
11. 11. UNICEF. State of the world’s children 2006. New York; 2005.
12. 12. Peters DH, Yazbeck AS, Sharma RR, Raman GNV, Pritchett LH, Wagstaff A. Better health systems for India’s poor: findings, analysis and options. Washington, DC: The World Bank; 2002.
13. 13. MF Yuen CC Cheng IJ Lauder SK Lam CG Ooi CL. Lai 2000 Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience Hepatology 31 330 5 10655254 10.1002/hep.510310211 1:STN:280:DC%2BD3c7it1egsw%3D%3D Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000;31:330–5.
14. 14. JP Kassirer AJ Mosokowitz J Lau SG. Pauker 1987 Decision analysis: a progress report Ann Intern Med 106 275 91 3541727 1:STN:280:BiiD1MfivFA%3D Kassirer JP, Mosokowitz AJ, Lau J, Pauker SG. Decision analysis: a progress report. Ann Intern Med. 1987;106:275–91.
15. 15. JR Beck SG. Pauker 1993 The Markov model in medical prognosis Med Decis Making 12 419 58 Beck JR, Pauker SG. The Markov model in medical prognosis. Med Decis Making. 1993;12:419–58.
16. 16. FP Sarasin E Giostra A. Hadengne 1996 Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis Am J Med 101 422 34 8873514 10.1016/S0002-9343(96)00197-0 1:STN:280:ByiD38jjslE%3D Sarasin FP, Giostra E, Hadengne A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med. 1996;101:422–34.
17. 17. S Saab D Ly J Nieto F Kanwal D Lu S Raman 2003 Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model Liver Transplant 7 672 81 10.1053/jlts.2003.50120 Saab S, Ly D, Nieto J, Kanwal F, Lu D, Raman S, et al. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transplant. 2003;7:672–81.
18. 18. MR Arguedas VK Chen MA Elboubeidi MB. Fallon 2003 Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost utility analysis Am J Gastroenterol 98 679 90 12650806 10.1111/j.1572-0241.2003.07327.x Arguedas MR, Chen VK, Elboubeidi MA, Fallon MB. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost utility analysis. Am J Gastroenterol. 2003;98:679–90.